Kate M. Smith

854 total citations
11 papers, 529 citations indexed

About

Kate M. Smith is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Kate M. Smith has authored 11 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Kate M. Smith's work include PARP inhibition in cancer therapy (8 papers), DNA Repair Mechanisms (5 papers) and Cancer therapeutics and mechanisms (2 papers). Kate M. Smith is often cited by papers focused on PARP inhibition in cancer therapy (8 papers), DNA Repair Mechanisms (5 papers) and Cancer therapeutics and mechanisms (2 papers). Kate M. Smith collaborates with scholars based in United Kingdom, Australia and Netherlands. Kate M. Smith's co-authors include Dominic I. James, Emma K. Grant, Helen E. Bryant, Polly Gravells, Donald Ogilvie, Allan M. Jordan, Ian D. Waddell, Bohdan Waszkowycz, Alison E. McGonagle and James R. Hitchin and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Cancer Cell and Cancer Research.

In The Last Decade

Kate M. Smith

11 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate M. Smith United Kingdom 8 313 290 129 88 80 11 529
Hardin Pantle United States 6 103 0.3× 140 0.5× 49 0.4× 66 0.8× 22 0.3× 7 373
Ken Cheng United States 13 111 0.4× 290 1.0× 38 0.3× 23 0.3× 3 0.0× 20 554
Sophie Routhier Canada 8 75 0.2× 194 0.7× 140 1.1× 41 0.5× 15 0.2× 8 534
Jenq‐Chang Lee Taiwan 12 72 0.2× 199 0.7× 65 0.5× 17 0.2× 13 0.2× 23 381
Zhaoyu Liu China 12 74 0.2× 245 0.8× 31 0.2× 75 0.9× 8 0.1× 17 405
Huadong Sun United States 8 61 0.2× 104 0.4× 23 0.2× 83 0.9× 8 0.1× 16 256
Liangshuo Hu China 11 97 0.3× 103 0.4× 94 0.7× 40 0.5× 3 0.0× 36 406
Ioannis Koutsounas Greece 12 132 0.4× 181 0.6× 92 0.7× 29 0.3× 2 0.0× 19 365
Jeong Eun Choi South Korea 9 113 0.4× 121 0.4× 68 0.5× 61 0.7× 7 0.1× 23 324

Countries citing papers authored by Kate M. Smith

Since Specialization
Citations

This map shows the geographic impact of Kate M. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate M. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate M. Smith more than expected).

Fields of papers citing papers by Kate M. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate M. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate M. Smith. The network helps show where Kate M. Smith may publish in the future.

Co-authorship network of co-authors of Kate M. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Kate M. Smith. A scholar is included among the top collaborators of Kate M. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate M. Smith. Kate M. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhang, Manqi, Yanhao Lai, Dominic I. James, et al.. (2020). Androgen Receptor and Poly(ADP-ribose) Glycohydrolase Inhibition Increases Efficiency of Androgen Ablation in Prostate Cancer Cells. Scientific Reports. 10(1). 3836–3836. 9 indexed citations
2.
Small, Helen, Kate M. Smith, Alison E. McGonagle, et al.. (2019). Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores – A cautionary disclosure. Bioorganic & Medicinal Chemistry Letters. 29(4). 560–562. 1 indexed citations
3.
Tighe, Anthony, Louisa Nelson, Samantha Littler, et al.. (2019). DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors. Cancer Cell. 35(3). 519–533.e8. 100 indexed citations
4.
Waszkowycz, Bohdan, Kate M. Smith, Alison E. McGonagle, et al.. (2018). Cell-Active Small Molecule Inhibitors of the DNA-Damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides. Journal of Medicinal Chemistry. 61(23). 10767–10792. 26 indexed citations
5.
Martin, Leenus, Tzuling Cheng, Dominic I. James, et al.. (2018). Abstract 1943: PARG inhibitors exhibit synthetic lethality with XRCC1 deficiency and a cellular mechanism of action that is distinct from PARP inhibition. Cancer Research. 78(13_Supplement). 1943–1943. 4 indexed citations
6.
Gravells, Polly, Emma K. Grant, Kate M. Smith, Dominic I. James, & Helen E. Bryant. (2017). Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase. DNA repair. 52. 81–91. 66 indexed citations
7.
Gravells, Polly, James R. Neale, Emma K. Grant, et al.. (2017). Radiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: A comparison with the PARP1/2/3 inhibitor olaparib. DNA repair. 61. 25–36. 42 indexed citations
8.
James, Dominic I., Kate M. Smith, Allan M. Jordan, et al.. (2016). First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib. ACS Chemical Biology. 11(11). 3179–3190. 94 indexed citations
9.
Shehabi, Yahya, Martin Štěrba, Peter Garrett, et al.. (2014). Procalcitonin Algorithm in Critically Ill Adults with Undifferentiated Infection or Suspected Sepsis. A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 190(10). 1102–1110. 130 indexed citations
10.
James, Dominic I., Allan M. Jordan, Nicola Hamilton, et al.. (2014). Abstract 2745: Pharmacological characterisation of cell active inhibitors of Poly(ADP-ribose) glycohydrolase (PARG). Cancer Research. 74(19_Supplement). 2745–2745. 2 indexed citations
11.
Raoof, Ali, Paul Depledge, Niall M. Hamilton, et al.. (2013). Toxoflavins and Deazaflavins as the First Reported Selective Small Molecule Inhibitors of Tyrosyl-DNA Phosphodiesterase II. Journal of Medicinal Chemistry. 56(16). 6352–6370. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hardin Pantle Breakdown of academic impact, for papers by Ken Cheng Breakdown of academic impact, for papers by Sophie Routhier Breakdown of academic impact, for papers by Jenq‐Chang Lee Breakdown of academic impact, for papers by Zhaoyu Liu Breakdown of academic impact, for papers by Huadong Sun Breakdown of academic impact, for papers by Liangshuo Hu Breakdown of academic impact, for papers by Ioannis Koutsounas Breakdown of academic impact, for papers by Jeong Eun Choi
Rankless by CCL
2026